Last updated 2026-07-27
- Went public on OTCBB (NSPR), May 2011
- Raised $8.1M PIPE, Oct 2014
- Raised $10M PIPE led by Hercules Capital, Inc., Sep 2013
Total raised
$24.5M
Last: PIPE 2025-07
Stage
Public
Founded
2005
Headcount
127
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
InspireMD is a medical technology company focused on innovative solutions for the treatment of vascular disease, advancing embolic protection to improve patient outcomes. The company utilizes its proprietary MicroNet® mesh platform technology to develop products for the prevention of stroke and treatment of complex vascular and coronary disease. InspireMD is publicly traded on Nasdaq under the ticker symbol NSPR.
Funding history · 19 rounds · $24.5M total
2026-04
Follow-on PO
Undisclosed
2025-08
Follow-on PO
Undisclosed
2025-07
PIPE
Undisclosed
2024-05
Follow-on PO
Undisclosed
2023-06
Follow-on PO
Undisclosed
2023-05
PIPE
Undisclosed
2021-04
Follow-on PO
Undisclosed
2021-02
PIPE
Undisclosed
2021-01
Follow-on PO
Undisclosed
2020-10
PIPE
Undisclosed
2020-07
Follow-on PO
Undisclosed
2017-10
Follow-on PO
Undisclosed
2016-06
Follow-on PO
Undisclosed
2014-10
PIPE
$8.1M
2013-09
PIPE
$10.0M
★ Hercules Capital, Inc.
2012-12
PIPE
$3.1M
2012-10
PIPE
$1.8M
2011-03
Follow-on PO
Undisclosed
2010-07
Convertible Debt
$1.6M
Headcount over time
From 41 (2018-12) to 117 (2026-03) · +76 (+185%) · 19 points · source: Finder history + radar grounding
Q&A
- What is InspireMD's primary focus as a medical technology company?
- InspireMD is a medical technology company focused on innovative solutions for the treatment of vascular disease, advancing embolic protection to improve patient outcomes. They utilize their proprietary MicroNet® mesh platform technology to develop products for the prevention of stroke and treatment of complex vascular and coronary disease.
- When did InspireMD announce the FDA approval for its CGuard® Prime Carotid Stent System?
- InspireMD announced FDA approval for its CGuard® Prime Carotid Stent System for the prevention of stroke on June 24, 2025.
- What was the most recent funding event for InspireMD and its amount?
- InspireMD completed a Public Offering in April 2026, raising $75,000,000.
- What was the total amount of capital raised by InspireMD through all its funding rounds?
- InspireMD has raised a total of $229,480,000 across all its funding rounds.
- What was a significant operational development for InspireMD in October 2024?
- In October 2024, InspireMD announced the establishment of its Global Headquarters in Miami, Florida, to support the anticipated U.S. launch and commercialization of the CGuard Prime Carotid Stent System.
- What was a key regulatory achievement for InspireMD in January 2024?
- In January 2024, InspireMD received CE Mark Recertification under the EU’s new Medical Device Regulation (MDR) Regulatory Framework.
- What was the purpose of the partnership between InspireMD and NAMSA announced in February 2025?
- In February 2025, InspireMD and NAMSA partnered on the CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for use in TCAR procedures.
- What was a notable leadership change announced by InspireMD in June 2025?
- In June 2025, InspireMD announced the appointment of Michael Lawless as Chief Financial Officer.
- What was the outcome of the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial announced in June 2023?
- In June 2023, InspireMD announced the completion of enrollment in the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial.
- What is the current employee count for InspireMD?
- InspireMD has 51-200 employees.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
vascularhospitalsmedical-devicessurgerycardiologypreventionstentdoctorshealthcare-providersclinicsneurovascularstroketreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | inspiremd.com |
|---|---|
| linkedin.com/company/2504112 | |
| facebook.com/InspireMD-Inc-1495734044064407 | |
| YouTube | youtube.com/user/InspireMD |
Identifiers & details
| Legal name | InspireMD, Inc. |
|---|---|
| Founded | 2005-4 |
| Employees (exact) | 127 |
| Offices | Winsen (Luhe) |
| Market cap | $75.4M |
| Status reason | Public on NYSE on Apr 2011; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| Public Offering | 2011-05 | OTCBB | NSPR | |
| Public Offering | 2019-09 | NYSE American | NSPR | $5.0M |
Radar intelligence
Patents
| EPO | 19 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | inspiremd.com |
|---|
Certificate / subdomain footprint
| Subdomains | 56 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513679431 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2005-04-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — annual_report (1), charge (2), people (2) |
| Registered address | מנורת המאור 4 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | דו~ח שנתי |
| 2025-10-23 | רישום שעבוד |
| 2025-07-14 | עדכון דירקטורים-הוספת דירקטור |
| 2025-07-14 | עדכון דירקטורים-הסרת דירקטור |
| 2025-12-03 | סילוק שעבוד |